Sukumar Nagendran - President and Head of R&D, Director at Taysha Gene Therapies, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and Head of R&D, Director
Stock Symbol
TSHA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sukumar Nagendran since 9/18/2023

Holdings reported by Sukumar Nagendran for Taysha Gene Therapies, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 898K $1.46M $1.63 Jan 2, 2024 Direct
Employee Stock Option (right to buy) 864K Jan 2, 2024 Direct Common Stock

Transactions reported by Sukumar Nagendran for Taysha Gene Therapies, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.